Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuanyuan Meng

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Advanced Materials (Deerfield Beach, Fla.)|April 16, 2026
Halide-Cation Interactions Enable Controlled Crystallization and Defect Minimization in High-Performance All-Perovskite TandemsJingnan Wang, Kexuan Sun, Lin Xie, et al.
Cell Reports|August 17, 2022
Nondegradable ubiquitinated ATG9A organizes Golgi integrity and dynamics upon stressesQian Luo, Qiangqiang Liu, Hongcheng Cheng, et al.
Nature Communications|May 5, 2026
Elongated grain morphology for efficient and radiant NIR-II Sn-based perovskite light-emitting diodesXiang Guan, Yuqing Li, Yu Su, et al.
Nature Communications|December 11, 2025
NRF1-mediated innate immune response drives inflammagingHong Lei, Tian Zhao, Jiaojiao Zhang, et al.
Elife|August 1, 2022
Hypoxia-induced proteasomal degradation of DBC1 by SIAH2 in breast cancer progressionQiangqiang Liu, Qian Luo, Jianyu Feng, et al.
Nature Nanotechnology|April 27, 2026
Chemical hardness engineering synchronizes crystallization in perovskite tandemsRuijia Tian, Kexuan Sun, Yuanyuan Meng, et al.
Nature Plants|May 11, 2023
Human activities and species biological traits drive the long-term persistence of old trees in human-dominated landscapesLi Huang, Cheng Jin, Yingji Pan, et al.
ACS Nano|October 12, 2022
Molecular Assembled Electrocatalyst for Highly Selective CO<sub>2</sub> Fixation to C<sub>2+</sub> ProductsPeng Wang, Tan Li, Qiqi Wu, et al.
The EMBO Journal|July 6, 2023
NRF1-mediated mitochondrial biogenesis antagonizes innate antiviral immunityTian Zhao, Jiaojiao Zhang, Hong Lei, et al.
Cryobiology|February 22, 2024
Is cryoablation still suitable for advanced non-small cell lung cancer after failure of first-line chemotherapy? A multicenter, prospective, randomized-controlled trial of eighty-seven patientsYu Chen, Xueni Fang, Dan Wang, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Advanced Materials (Deerfield Beach, Fla.)|April 16, 2026
Halide-Cation Interactions Enable Controlled Crystallization and Defect Minimization in High-Performance All-Perovskite TandemsJingnan Wang, Kexuan Sun, Lin Xie, et al.
Cell Reports|August 17, 2022
Nondegradable ubiquitinated ATG9A organizes Golgi integrity and dynamics upon stressesQian Luo, Qiangqiang Liu, Hongcheng Cheng, et al.
Nature Communications|May 5, 2026
Elongated grain morphology for efficient and radiant NIR-II Sn-based perovskite light-emitting diodesXiang Guan, Yuqing Li, Yu Su, et al.
Nature Communications|December 11, 2025
NRF1-mediated innate immune response drives inflammagingHong Lei, Tian Zhao, Jiaojiao Zhang, et al.
Elife|August 1, 2022
Hypoxia-induced proteasomal degradation of DBC1 by SIAH2 in breast cancer progressionQiangqiang Liu, Qian Luo, Jianyu Feng, et al.
Nature Nanotechnology|April 27, 2026
Chemical hardness engineering synchronizes crystallization in perovskite tandemsRuijia Tian, Kexuan Sun, Yuanyuan Meng, et al.
Nature Plants|May 11, 2023
Human activities and species biological traits drive the long-term persistence of old trees in human-dominated landscapesLi Huang, Cheng Jin, Yingji Pan, et al.
ACS Nano|October 12, 2022
Molecular Assembled Electrocatalyst for Highly Selective CO<sub>2</sub> Fixation to C<sub>2+</sub> ProductsPeng Wang, Tan Li, Qiqi Wu, et al.
The EMBO Journal|July 6, 2023
NRF1-mediated mitochondrial biogenesis antagonizes innate antiviral immunityTian Zhao, Jiaojiao Zhang, Hong Lei, et al.
Cryobiology|February 22, 2024
Is cryoablation still suitable for advanced non-small cell lung cancer after failure of first-line chemotherapy? A multicenter, prospective, randomized-controlled trial of eighty-seven patientsYu Chen, Xueni Fang, Dan Wang, et al.
Pageof 13